Measles-containing-vaccine first-dose (MCV1) immunization coverage in Americas (WHO region)
Americas (WHO region): Measles-containing-vaccine first-dose (MCV1) immunization coverage was 88.0% in 2025. ▼ Falling
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Americas (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Americas (WHO region) recorded 88.0% for measles-containing-vaccine first-dose (mcv1) immunization coverage in 2025.
That represents a change of down 1.1% on the previous year and down 5.4% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Americas (WHO region) peaked at 94.0% in 2001 and was at its lowest, 85.0%, in 2022.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Americas (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 93.0% | — |
| 2001 | 94.0% | +1.1% |
| 2002 | 93.0% | -1.1% |
| 2003 | 94.0% | +1.1% |
| 2004 | 93.0% | -1.1% |
| 2005 | 92.0% | -1.1% |
| 2006 | 94.0% | +2.2% |
| 2007 | 93.0% | -1.1% |
| 2008 | 94.0% | +1.1% |
| 2009 | 93.0% | -1.1% |
| 2010 | 93.0% | +0.0% |
| 2011 | 94.0% | +1.1% |
| 2012 | 94.0% | +0.0% |
| 2013 | 92.0% | -2.1% |
| 2014 | 93.0% | +1.1% |
| 2015 | 93.0% | +0.0% |
| 2016 | 92.0% | -1.1% |
| 2017 | 88.0% | -4.3% |
| 2018 | 91.0% | +3.4% |
| 2019 | 87.0% | -4.4% |
| 2020 | 86.0% | -1.1% |
| 2021 | 86.0% | +0.0% |
| 2022 | 85.0% | -1.2% |
| 2023 | 87.0% | +2.4% |
| 2024 | 89.0% | +2.3% |
| 2025 | 88.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 93.3% | 92.0% | 94.0% | 10 |
| 2010s | 91.7% | 87.0% | 94.0% | 10 |
| 2020s | 86.8% | 85.0% | 89.0% | 6 |
More health data for Americas (WHO region)
- Pertussis - number of reported cases, gaps filled 24,640 (2025)
- Measles - number of reported cases, gaps filled 12,380 (2025)
- Diphtheria - number of reported cases, gaps filled 72 (2025)
- Total tetanus - number of reported cases, gaps filled 385 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 23 (2025)
- Number of under-five deaths, annual growth rate -2.83 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.68 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.22 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 22.22 % change on previous year (2024)
- Pertussis - number of reported cases, annual growth rate -20.67 % change on previous year (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Americas (WHO region)?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Americas (WHO region) was 88.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Americas (WHO region)?
- The highest recorded value was 94.0% in 2001.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Americas (WHO region)?
- The lowest recorded value was 85.0% in 2022.
- How does Americas (WHO region) rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Americas (WHO region) ranks 9th out of 17 groups with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Americas (WHO region)?
- Over the last ten years it is down 5.4%. The long-run trend across the full record is falling.
- Where does this Americas (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).